Colon Cancer - Genentech asks for expanded use of Avastin
Genentech asks for expanded use of Avastin
San Francisco Business Journal - The South San Francisco company (NYSE: DNA) said Monday it has turned in a supplemental application with the Food and Drug Administration seeking approval to sell the drug to treat relapsed
FDA partially rejects American Longevity’s health claims for lycopene
Food Consumer - 1. 1) “Lycopene may reduce your risk of certain forms of
Genentech Asks For Expanded Use of Avastin and Pfizer Stocks Jump On
Financial News USA - Genentech Asks For Expanded Use of Avastin and Pfizer Stocks Jump On Lipitor Ruling City of Industry, CA –(www.FinancialNewsUSA.com)– 12/20/2005 - Biotechnology industry news provided by Financial News USA (OTC: FNWU) Genentech Inc. (NYSE: DNA) has
New surgical procedures, treatments possible solutions for stemming
Chanute Tribune - Densmore Hart and Dr. Claude Brachfeld came to an agreement early on about his care at Hutchinson Heart. Hart, an avid golfer, told the physician he planned on walking the Old Course at St. Andrews, in Scotland. It’s nearly 3.5 miles from the first